期刊文献+

降脂理肝汤对非酒精性脂肪肝大鼠肠黏膜屏障的影响 被引量:7

Effects of Jiangzhi Ligan Decoction on Intestinal Mucosal Barrier in Rats with Non-alcoholic Fatty Liver Disease
下载PDF
导出
摘要 目的观察降脂理肝汤对非酒精性脂肪肝大鼠肠黏膜屏障的影响,探讨降脂理肝汤干预非酒精性脂肪肝的机制。方法40只SD雄性大鼠随机分为正常组(10只)和造模组(30只),采用高脂饮食喂养复制非酒精性脂肪肝(non-alcoholic fatty liver disease,NAFLD)大鼠模型,造模组大鼠再随机分为高脂饮食模型组、降脂理肝汤低剂量及高剂量组(4.6、9.2g/kg),分别予以相应干预6周后取小肠和门静脉血液,检测肠黏膜结构、紧密连接蛋白(Occludin)和ZO-1蛋白水平以及血浆内毒素水平。结果与正常组比较,高脂饮食大鼠小肠绒毛稀疏且排列不整齐、小肠绒毛高度明显降低(P<0.01),Occludin和ZO-1蛋白表达水平显著降低(P<0.05),血浆内毒素水平显著上升(P<0.01)。与高脂饮食模型组比较,高剂量降脂理肝汤组小肠绒毛排列较整齐,断裂较少,绒毛高度显著升高(P<0.01),Occludin和ZO-1蛋白水平显著上升(P<0.05),血浆内毒素水平明显降低(P<0.01);而低剂量降脂理肝汤组仅显著降低了血浆内毒素水平(P<0.01)。结论降脂理肝汤干预非酒精性脂肪肝的机制可能与其改善小肠绒毛结构,恢复Occludin和ZO-1蛋白水平从而减轻肠黏膜屏障损伤,降低血浆中的内毒素水平有关。 Objective To explore the effects of Jiangzhi Ligan Decoction (JZLGT) on intestinal mucosal barrier in rats with non-alcoholic fatty liver disease (NAFLD),and to explore the intervention mechanism of JZLGT in NAFLD.Methods Forty male Sprague-Dawley (SD) rats were divided into a normal diet (ND) group (10 rats) and a model group (30 rats).NAFLD rat model was successfully replicated by high-fat diet (HFD) feeding.Then the 30 rats in the model group were randomly divided into a HFD model group,a JZLGT-Low group and a JZLGT-High group (treated with 4.6 and 9.2 g/kg,respectively).After 6 weeks of corresponding intervention,blood of intestine and portal vein was collected.The structure of intestinal mucosa,levels of Occludin,ZO-1 and plasma endotoxin were determined.Results Compared with the ND group,the villi of the small intestine in the HFD rats were sparse and irregularly ranged,with the length of the small intestinal villi dramatically decreased (P<0.01);the expression levels of Occludin and ZO-1 were significantly decreased (P<0.05),and the plasma endotoxin level was notably increased (P<0.01).Compared with the HFD model group,the villi of the small intestine in the JZLGT-High group were neatly ranged and less fractured,with the length of villi obviously increased (P<0.01);the levels of Occludin and ZO-1 were remarkably increased (P<0.05),and the plasma endotoxin level was significantly decreased (P<0.01).However,only the plasma endotoxin level was decreased significantly in rats of the JZLGT-Low group (P<0.01).Conclusion The intervention mechanism of JZLGT on NAFLD may be related to the structural improvement of small intestinal villi and the restored expression levels of Occludin and ZO-1 proteins,which can relieve the injury of intestinal mucosal barrier and decrease the level of plasma endotoxin.
作者 尹抗抗 王柏果 徐琦 程婉红 邓天好 谭达全 唐标 YIN Kangkang;WANG Baiguo;XU Qi;CHENG Wanhong;DENG Tianhao;TAN Daquan;TANG Biao(Hunan University of Chinese Medicine,Changsha,Hunan 410208,China)
机构地区 湖南中医药大学
出处 《湖南中医药大学学报》 CAS 2019年第9期1089-1093,共5页 Journal of Hunan University of Chinese Medicine
基金 湖南省大学生研究性学习与创新性实验计划项目[湘教办通〔2017〕116号(序号311)] 2017年湖南省卫计委科研计划项目(C2017028) 2016年湖南省湖南中医药科研计划项目一般课题(201664,201844)
关键词 降脂理肝汤 非酒精性脂肪肝病 肠黏膜屏障 OCCLUDIN蛋白 ZO-1蛋白 内毒素 Jiangzhi Ligan Decoction non-alcoholic fatty liver disease intestinal mucosal barrier Occludin protein ZO-1 protein endotoxin
  • 相关文献

参考文献5

二级参考文献63

  • 1于勇.IgA在肠道免疫屏障中的作用及其创伤后的改变[J].国外医学(创伤与外科基本问题分册),1994,15(1):15-18. 被引量:12
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1510
  • 3中华中医药学会脾胃病分会.中医消化病诊疗指南[M].北京:中国中医药出版社,2006.
  • 4Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010; 52: 1836-1846.
  • 5Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, Mascianà R, Forgione A, Gabrieli ML, Perotti G, Vecchio FM, Rapaccini G, Gasbarrini G, Day CP, Grieco A. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009; 49: 1877-1887.
  • 6Rahimi AR, Daryani NE, Ghofrani H, Taher M, Pashaei MR, Abdollahzade S, Kalani M, Ajdarkosh H. The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran. Turk J Gastroenterol 2011; 22: 300-304.
  • 7Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
  • 8Lefkowitch JH, Haythe JH, Regent N. Kupffer cell aggregation and perivenular distribution in steatohepatitis. Mod Pathol 2002; 15: 699-704.
  • 9Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001; 48: 206-211.
  • 10Hofmann AF. Bile Acids: The Good, the Bad, and the Ugly. News Physiol Sci 1999; 14: 24-29.

共引文献63

同被引文献118

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部